News
Garber Announces Advisory Committee for Harvard Law School Dean Search
News
First Harvard Prize Book in Kosovo Established by Harvard Alumni
News
Ryan Murdock ’25 Remembered as Dedicated Advocate and Caring Friend
News
Harvard Faculty Appeal Temporary Suspensions From Widener Library
News
Man Who Managed Clients for High-End Cambridge Brothel Network Pleads Guilty
The Food and Drug Administration, which is currently revising rules governing the testing of new drugs, has shown good sense in its promise to the National Institute of Health that the new rules will not hinder qualified researchers. New discoveries are made more rapidly in medicine than perhaps any other field. While it is essential that the rules be tightened to prevent another mishap like the one which produced thousands of thalidomide-deformed babies, it is equally important that legitimate, controlled testing be carried on unhampered, so that the benefits of research may quickly reach the patient.
Want to keep up with breaking news? Subscribe to our email newsletter.